Investigating how GPR39 affects cognitive impairment related to aging and blood vessel health
Role of GPR39 in Aging-Related Vascular Cognitive Impairment (VCI)
This study is looking at how a special receptor called GPR39 helps protect brain blood vessels and keep our thinking sharp as we get older, which could lead to new ways to prevent or treat vascular cognitive impairment, a common cause of dementia.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-10538329 on NIH RePORTER |
What this research studies
This research focuses on understanding vascular cognitive impairment (VCI), which is a significant cause of dementia. It explores the role of a specific receptor, GPR39, in protecting brain blood vessels and maintaining cognitive function as people age. By studying transgenic mice that mimic human conditions, the research aims to uncover the mechanisms behind blood flow regulation in the brain and how it relates to cognitive decline. The findings could lead to new therapeutic strategies for preventing or treating VCI.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults experiencing cognitive decline or those at risk for vascular cognitive impairment.
Not a fit: Patients with cognitive impairment due to causes other than vascular issues, such as Alzheimer's disease, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that help preserve cognitive function in aging individuals by improving blood flow in the brain.
How similar studies have performed: Previous research has shown promising results in understanding the role of similar signaling pathways in cognitive health, suggesting that this approach may yield valuable insights.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Alkayed, Nabil J — Oregon Health & Science University
- Study coordinator: Alkayed, Nabil J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.